Japan Science and Technology Agency

Total investments

36

Average round size

6M

Portfolio companies

27

Rounds per year

1.71

Lead investments

1

Follow on index

0.22

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsRoboticsManufacturingMedical DeviceMedicalElectronicsmHealthNursing and Residential Care

Summary

The venture was found in Asia in Japan. The main department of described Corporate Investor is located in the Tokyo.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Among the most popular portfolio startups of the fund, we may highlight Axelspace, REGiMMUNE Corporation. Among the most successful fund investment fields, there are Aerospace, National Security. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Japan Science and Technology Agency, startups are often financed by Yasuda Enterprise Development, NIF SMBC Ventures, Japan Asia Investment. The meaningful sponsors for the fund in investment in the same round are Beyond Next Ventures, Mitsubishi UFJ Capital, ITOCHU Technology Ventures. In the next rounds fund is usually obtained by UTokyo Innovation Platform, SMBC Venture Capital, Mitsubishi UFJ Capital.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018.

Show more

Investments analytics

Analytics

Total investments
36
Lead investments
1
Rounds per year
1.71
Follow on index
0.22
Investments by industry
  • Biotechnology (13)
  • Manufacturing (9)
  • Health Care (9)
  • Medical (8)
  • Medical Device (4)
  • Show 39 more
Investments by region
  • Japan (36)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
26M
Group Appearance index
0.83

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Algal Bio 29 Nov 2019 Biotechnology, Food and Beverage Early Stage Venture 3M Japan, Chiba Prefecture, Kashiwa
01 Jan 2020 Internet, Information Technology, Communities Seed United States, California, San Francisco
Kwely 25 Apr 2022 Retail, B2B Seed 700K Senegal, Dakar, Dakar
MainBot 04 Jun 2019 Education, Robotics, Edutainment Seed 780K Ile-de-France, France, France
Richmedia 22 Dec 2011 Social, Web Browsers, SEO Seed 172K Hokkaido Prefecture, Japan, Japan
ThinkCyte 15 Jun 2018 Biotechnology, Life Science, Therapeutics Seed 3M Bunkyo, Japan
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.